Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick Noud

Orthopaedic Surgery Lansing, MI Medical Doctor

NPI 1477685790 CMS profile 293543

2815 S Pennsylvania Ave, Suite 204, Lansing, MI 48910

Open in the dashboard

General payments

$282,007

309 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$160,000

2 holdings reported · through program year 2025

Through program year 2025, Patrick Noud of Lansing, MI is reported in the CMS Open Payments database as having received $282,007 across 309 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $160,000 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $31,313 28
2024 General $35,790 29
2023 General $30,437 33
2022 General $47,963 62
2021 General $37,221 33
2020 General $37,208 32
2019 General $62,075 92
2025 Ownership $80,000 1
2024 Ownership $80,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick Noud
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Patrick Noud were reported at $31,313. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Patrick Noud Orthopaedic Surgery median Middle half National median
2019 $62,075 $644 $140–$2,844 $163
2020 $37,208 $312 $75–$1,860 $114
2021 $37,221 $520 $117–$2,495 $132
2022 $47,963 $598 $128–$2,731 $149
2023 $30,437 $461 $128–$2,264 $160
2024 $35,790 $497 $134–$2,475 $164
2025 $31,313 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lima USA, Inc. $104,386 102 payments
  2. TechMah Medical, LLC $63,702 51 payments
  3. Encore Medical, LP $43,323 24 payments
  4. Catalyst OrthoScience $36,252 39 payments
  5. Limacorporate S.p.A. $28,777 20 payments
  6. Stryker Corporation $2,616 17 payments
  7. Smith+Nephew, Inc. $1,236 18 payments
  8. Heron Therapeutics, Inc. $351 3 payments
  9. Abbott Laboratories $344 4 payments
  10. AbbVie, Inc. $130 2 payments
  11. Other $888 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $206,919 78 payments
  2. Travel and Lodging $64,537 90 payments
  3. Food and Beverage $10,551 141 payments
Products named General payments · program years 2019–2025
  1. SMR $51,708 74 payments
  2. SmartSpace Shoulder $47,299 26 payments
  3. SMR Shoulder Devices $45,535 25 payments
  4. DJO SURGICAL $25,691 9 payments
  5. SMR SHOULDER Smr $15,721 3 payments
  6. Smart SPACE $14,904 24 payments
  7. Catalyst Total CSR $14,026 10 payments
  8. Product Portfolio $13,229 7 payments
  9. Promade $4,725 8 payments
  10. Catalyst CSR Shoulder System $4,672 2 payments
  11. Other $20,652 164 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

113

Median for Orthopedic Surgery: 203

Drug cost

$273

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Meloxicam Generic 62 $139
Cephalexin Generic 24 $81
Amoxicillin Generic 27 $53

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$105,824

Of which drugs: $243

Medicare patients

213

Average age 73

Services billed

720

122 women, 91 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 32%
Depression 28%
Chronic kidney disease 26%
Ischemic heart disease 23%
Atrial fibrillation 19%
COPD 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 18 44 $243

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

309 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record